MTEMのニュース
Oppenheimer Analysts Decrease Earnings Estimates for Molecular Templates, Inc. (NASDAQ:MTEM) 2023/04/07 05:42:46 The AM Reporter
Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) – Equities research analysts at Oppenheimer lowered their Q1 2023 EPS estimates for Molecular Templates in a research note issued to investors on Monday, April 3rd. Oppenheimer analyst F. Brisebois now forecasts that the biotechnology company will post earnings per share of ($0.33) for the quarter, down from […]
Molecular Templates GAAP EPS of -$0.39 misses by $0.09, revenue of $2.6M misses by $6.21M 2023/03/31 07:46:54 Seeking Alpha
Molecular Templates press release (MTEM): Q4 GAAP EPS of -$0.39 misses by $0.09.Revenue of $2.6M (-85.6% Y/Y) misses by $6.21M.As of December 31, 2022, MTEM’s cash and…
Is Molecular Templates Inc. (NASDAQ:MTEM) stock a better investment at this time? 2023/03/13 17:40:00 US Post News
Currently, Molecular Templates Inc.’s (MTEM) stock is trading at $0.35, marking a fall of -30.60% from last night’s close. At this price, the stock is -90.36% below its 52-week high of $3.64 and 13.10% above its 52-week low of $0.31. The 200-day Simple moving average is often placed more emphasis on by traders because of […]
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/03/10 17:58:38 Benzinga
Gainers Barnes & Noble Education, Inc. (NYSE: BNED ) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. Molecular Templates, Inc. (NASDAQ: MTEM ) rose 29.7% to $0.61. Molecular Templates received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program. Jeffs'' Brands Ltd (NASDAQ: JFBR ) gained 23% to $1.7110. Jeffs'' Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million. PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) gained 20.5% to $4.1814 after reporting upbeat quarterly results. Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) shares rose 19.7% to $2.47 after jumping 27% on Thursday. The company recently announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. PlayAGS, Inc. (NYSE: AGS ) shares gained 18.3% to $7.51 after the company posted better-than-expected Q4 results. Mannatech, Incorporated (NASDAQ: MTEX ) rose 18.2% to $21.00.
Nasdaq Down 50 Points; PlayAGS Shares Spike Higher 2023/03/10 17:03:49 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday. The Dow traded down 0.21% to 32,188.00 while the NASDAQ fell 0.50% to 11,281.98. The S&P 500 also fell, dropping, 0.39% to 3,903.04. Check This Out: United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday Leading and Lagging Sectors Energy shares rose by 1.3% on Friday. Meanwhile, top gainers in the sector included Gevo, Inc. (NASDAQ: GEVO ), up 9%, and Battalion Oil Corporation (NYSE: BATL ), up 4%. In trading on Friday, real estate shares dipped by 0.6%. Top Headline The US economy unexpectedly added 311,000 jobs in February, well above market estimates of 205,000, and compared to revised 504,000 in January. The unemployment rate rose to 3.6% in February versus a 50-year low of 3.4% recorded in January. Equities Trading UP PlayAGS, Inc. (NYSE: AGS ) shares shot up 23% to $7.84 after the company posted better-than-expected Q4 results. Shares of PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) got a boost, shooting 19% to $4.1462 after reporting upbeat quarterly results.
Molecular Templates GAAP EPS of -$0.39 misses by $0.09, revenue of $2.6M misses by $6.21M 2023/03/31 07:46:54 Seeking Alpha
Molecular Templates press release (MTEM): Q4 GAAP EPS of -$0.39 misses by $0.09.Revenue of $2.6M (-85.6% Y/Y) misses by $6.21M.As of December 31, 2022, MTEM’s cash and…
Is Molecular Templates Inc. (NASDAQ:MTEM) stock a better investment at this time? 2023/03/13 17:40:00 US Post News
Currently, Molecular Templates Inc.’s (MTEM) stock is trading at $0.35, marking a fall of -30.60% from last night’s close. At this price, the stock is -90.36% below its 52-week high of $3.64 and 13.10% above its 52-week low of $0.31. The 200-day Simple moving average is often placed more emphasis on by traders because of […]
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/03/10 17:58:38 Benzinga
Gainers Barnes & Noble Education, Inc. (NYSE: BNED ) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. Molecular Templates, Inc. (NASDAQ: MTEM ) rose 29.7% to $0.61. Molecular Templates received FDA clearance to proceed for clinical testing of its novel MT-8421 ETB program. Jeffs'' Brands Ltd (NASDAQ: JFBR ) gained 23% to $1.7110. Jeffs'' Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million. PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) gained 20.5% to $4.1814 after reporting upbeat quarterly results. Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) shares rose 19.7% to $2.47 after jumping 27% on Thursday. The company recently announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. PlayAGS, Inc. (NYSE: AGS ) shares gained 18.3% to $7.51 after the company posted better-than-expected Q4 results. Mannatech, Incorporated (NASDAQ: MTEX ) rose 18.2% to $21.00.
Nasdaq Down 50 Points; PlayAGS Shares Spike Higher 2023/03/10 17:03:49 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday. The Dow traded down 0.21% to 32,188.00 while the NASDAQ fell 0.50% to 11,281.98. The S&P 500 also fell, dropping, 0.39% to 3,903.04. Check This Out: United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday Leading and Lagging Sectors Energy shares rose by 1.3% on Friday. Meanwhile, top gainers in the sector included Gevo, Inc. (NASDAQ: GEVO ), up 9%, and Battalion Oil Corporation (NYSE: BATL ), up 4%. In trading on Friday, real estate shares dipped by 0.6%. Top Headline The US economy unexpectedly added 311,000 jobs in February, well above market estimates of 205,000, and compared to revised 504,000 in January. The unemployment rate rose to 3.6% in February versus a 50-year low of 3.4% recorded in January. Equities Trading UP PlayAGS, Inc. (NYSE: AGS ) shares shot up 23% to $7.84 after the company posted better-than-expected Q4 results. Shares of PLAYSTUDIOS, Inc. (NASDAQ: MYPS ) got a boost, shooting 19% to $4.1462 after reporting upbeat quarterly results.
Why Is Molecular Templates (MTEM) Stock Up 36% Today? 2023/03/10 13:01:57 InvestorPlace
Molecular Templates (MTEM) stock is rocketing higher on Friday after the company got approval from the FDA for a clinical trial.
Looking Into Molecular Templates''s Return On Capital Employed 2022/12/22 14:49:38 Benzinga
Molecular Templates (NASDAQ: MTEM ) brought in sales totaling $4.24 million during Q3 according to data provided by Benzinga Pro . However, earnings decreased 0.89%, resulting in a loss of $24.64 million. Molecular Templates collected $4.42 million in revenue during Q2, but reported earnings showed a $24.42 million loss. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and … Full story available on Benzinga.com
Molecular Templates Earnings, Revenue Beat in Q3 By Investing.com 2022/11/11 05:59:00 Investing.com
Molecular Templates Earnings, Revenue Beat in Q3
Molecular Templates GAAP EPS of -$0.44 beats by $0.04, revenue of $4.24M beats by $1.16M (NASDAQ:MTEM) 2022/11/10 22:11:53 Seeking Alpha
Molecular Templates press release (NASDAQ:MTEM): Q3 GAAP EPS of -$0.44 beats by $0.04.Revenue of $4.24M (+78.2% Y/Y) beats by $1.16M.
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results 2022/11/10 21:15:00 GlobeNewswire
AUSTIN, Texas, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases, today reported financial results and business updates for the third quarter of 2022.